Catalyst Wire Dossier Catalyst Wire Dossier

EP1300 polyepitope DNA vaccine

· National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EP1300 polyepitope DNA vaccine, covering 2012-11-16 to 2012-11-16. Get the full timeline:

Most recent: Clinical Trial Update: EP1300 Polyepitope DNA Vaccine Against Plasmodium Falciparum Malaria [Phase 1]

See pricing